Navigation Links
Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008
Date:3/31/2008

yees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward- looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2007, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission (SEC) and available in the "Investors" section of our Website under the heading "SEC Filings." We also may make forward-looking statements about the benefits of the merger of Thermo Electron and Fisher Scientific, including statements about future financial and operating results, the new company's plans, ob
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
2. Thermo Fisher Scientific to Present at Investor Conferences
3. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
4. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
5. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
6. Thermo Fisher Scientific to Present at Upcoming Investor Conferences
7. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
8. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
9. Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 25, 2007
10. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
11. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...
(Date:5/21/2013)... 21, 2013 PathoGenetix, Inc., a commercial-stage ... typing, announced today that it has successfully identified and ... strains obtained from the Centers for Disease Control and ... technology. The findings are detailed in a poster ... Society for Microbiology in Denver on Monday. , The ...
(Date:5/20/2013)... 2013 Grace Century , an ... life science and health related private equity projects, has ... International Project Team. Dergham's expertise in finance and international ... to Grace Century as it continues to look at ... Dergham holds both an under graduate degree from the ...
(Date:5/20/2013)... Calif. , May 20, 2013  (PSHR) ... providing naturally based products across a broad range ... company has retained investor relations firm, BlueWater Advisory ... the return to trading process, and to direct ... trading initiation. Matthew Mills ...
Breaking Biology Technology:Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2
... - Probing the last genomic frontier of higher organisms, an ... understood - but critical - genetic domain in rice. , ... professor of horticulture at the University of Wisconsin-Madison , ... Research in Rockville, Md., has exposed a supposedly barren ...
... Wis. - Chippewa Valley Technical College (CVTC) ... that CVTC will begin teaching nanotechnology as early as ... sweeping changes and opportunities. , ,Jack Uldrich, nanotechnology author, ... described a shift of historic proportions brought on by ...
... , a Wisconsin-based developer of e-Catalog business solutions ... distribution networks, announced it has expanded its software ... , a manufacturer of products for the lawn ... Cub Cadet, Troy-Bilt, Yard-Man, Ryobi, Yard Machines, McCulloch ...
Cached Biology Technology:Rice Centromere, Supposedly Quiet Genetic Domain, Surprises 2Rice Centromere, Supposedly Quiet Genetic Domain, Surprises 3Chippewa Valley Embraces Nanotechnology 2ARI Links e-Catalog Deal with Outdoor Power Equipment Manufacturer 2
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
(Date:5/20/2013)... ITHACA, N.Y. Little is known about the effect ... new study from Cornell University finds that increasing the ... class reduces the probability of obesity. , The study ... effect of PE on youth obesity, and is forthcoming ... An early, online version of the study can be ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... The Food and Drug Administration (FDA) today issued a ... and patient caregivers to new safety information concerning an ... antipsychotic drugs." These drugs are approved for the treatment ... drugs to treat behavioral disorders in elderly patients with ...
... mammalian behavior, physiology, and biochemistry are controlled by the ... suprachiasmatic nucleus (SCN). The clock is synchronized to environmental ... from everyday experience, that adjusting to new light schedules ... adaptation takes place are not well understood. Researchers now ...
... results from a large, randomized clinical trial for ... cancer ?cancer that has spread from the breast ... those patients who received bevacizumab (Avastin? in combination ... before their cancer progressed than patients who received ...
Cached Biology News:FDA Warns About Antipsychotic Drugs and Elderly 2After a time-shift, mixed signals from the circadian clock 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 2Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer 3
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
ANTI MYCOBACTERIUM TUBERCULOSIS...
IMAGEQUANT 100 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: